Singapore markets open in 5 hours 13 minutes
Straits Times Index
3,332.80 -10.55 (-0.32%) S&P 500
5,460.48 -22.39 (-0.41%) Dow
39,118.86 -45.24 (-0.12%) Nasdaq
17,732.60 -126.10 (-0.71%) Bitcoin USD
61,975.25 +1,031.29 (+1.69%) CMC Crypto 200
1,285.62 +1.79 (+0.14%)
MAIA Biotechnology, Inc. (MAIA)
NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 3.3300 |
| Open | 3.6900 |
| Bid | 3.3200 x 2900 |
| Ask | 3.4600 x 2200 |
| Day's range | 3.2901 - 3.7050 |
| 52-week range | 0.8200 - 5.9900 |
| Volume | |
| Avg. volume | 369,698 |
| Market cap | 74.683M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.5700 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 12.63 |
Business WireMAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA’s Approval of a Telomerase Inhibitor Agent Therapy
CHICAGO, June 07, 2024--MAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA’s Approval of a Telomerase Inhibitor Agent Therapy
Business WireMAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer Agent
CHICAGO, June 06, 2024--MAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer Agent
Business WireMAIA Biotechnology Reveals New Clinical Data Showing THIO’s Strong Efficacy in Non-Small Cell Lung Cancer
CHICAGO, June 04, 2024--MAIA Biotechnology Reveals New Clinical Data Showing THIO’s Strong Efficacy in Non-Small Cell Lung Cancer
© 2024 Yahoo. All rights reserved.